We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
83 hedge funds and large institutions have $45.4M invested in Zevra Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
8% more funds holding
Funds holding: 77 → 83 (+6)
5.1% more ownership
Funds ownership: 20.64% → 25.74% (+5.1%)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
1% more call options, than puts
Call options by funds: $6.61M | Put options by funds: $6.54M
28% less capital invested
Capital invested by funds: $63.1M → $45.4M (-$17.7M)
Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
23
Reduced
21
Closed
12
Calls
$6.61M
Puts
$6.54M
Net Calls
+$68K
Net Calls Change
-$7.29M
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.04M |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$1.62M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.52M |
| 4 |
Renaissance Technologies
New York
|
+$1.03M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$952K |
